All News
Vax Skeptic to Lead Autism Study; Liver Damage After RFK Jr. Recs; 'Chemtrail' Bans?
(MedPage Today) -- Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts.
Read MoreSTAT+: Pharmalittle: We’re reading about drug net prices inching up, uncertain pharma M&A, and more
Investment bankers say large pharma and biotech deals are stalling as executives grapple with mercurial White House economic policies
Read MoreSTAT+: Wave to submit Duchenne drug for approval after Phase 2 success
Wave Life Sciences’ experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, setting the stage for a new therapeutic option for patients.
Read MoreAbbreviated New Drug Application (ANDA) Forms and Submission Requirements
The FDA aspires to assist applicants in developing abbreviated new drug applications (ANDAs).
Read MoreThe need-to-know on yesterday’s health leadership votes & noms
And more of the essential health news stories of the day.
Read MoreApprovals & Reports
FDA publishes a list of first-time approvals to manufacture generic drugs and a variety of reports on generic drug application reviews.
Read MoreSenate Confirms Trump's Nominees to Head NIH and FDA
(MedPage Today) -- The Senate on Tuesday evening confirmed Jay Bhattacharya, MD, as the next NIH director, and Marty Makary, MD, MPH, as the next FDA commissioner.
Read MoreGlobalData forecasts China neurosurgical robotics market to grow at 10% CAGR through 2036
China’s neurosurgical robotics market expansion driven by rising demand for precision surgery and strategic local partnerships
Read MoreFDA approves cabozantinib for adults and pediatric patients 12 years of age and older with pNET and epNET
On March 26, 2025, the FDA approved cabozantinib (Cabometyx, Exelixis, Inc.
Read MoreRGCON 2025 highlights innovations in gynecological cancer care
Gynecological cancers in India expected to rise by 55 per cent by 2040; Experts call for urgent action and preventive measures
Read More